NeuroOne Medical Statistics Share Statistics NeuroOne Medical has 49.94M
shares outstanding. The number of shares has increased by 61.68%
in one year.
Shares Outstanding 49.94M Shares Change (YoY) 61.68% Shares Change (QoQ) 61.42% Owned by Institutions (%) 6.2% Shares Floating 44.01M Failed to Deliver (FTD) Shares 4,000 FTD / Avg. Volume 1.54%
Short Selling Information The latest short interest is 212.26K, so 0.42% of the outstanding
shares have been sold short.
Short Interest 212.26K Short % of Shares Out 0.42% Short % of Float 0.43% Short Ratio (days to cover) 1.26
Valuation Ratios The PE ratio is -2.15 and the forward
PE ratio is -5.92.
NeuroOne Medical's PEG ratio is
0.07.
PE Ratio -2.15 Forward PE -5.92 PS Ratio 7.67 Forward PS 3.6 PB Ratio 32.23 P/FCF Ratio -2.38 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NeuroOne Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.09,
with a Debt / Equity ratio of 0.32.
Current Ratio 2.09 Quick Ratio 0.9 Debt / Equity 0.32 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage -51.91
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $203.12K Profits Per Employee $-724.59K Employee Count 17 Asset Turnover 0.64 Inventory Turnover 0.9
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 6.02% in the
last 52 weeks. The beta is 0.72, so NeuroOne Medical's
price volatility has been higher than the market average.
Beta 0.72 52-Week Price Change 6.02% 50-Day Moving Average 0.79 200-Day Moving Average 0.81 Relative Strength Index (RSI) 63.05 Average Volume (20 Days) 259,680
Income Statement In the last 12 months, NeuroOne Medical had revenue of 3.45M
and earned -12.32M
in profits. Earnings per share was -0.46.
Revenue 3.45M Gross Profit 1.08M Operating Income -11.89M Net Income -12.32M EBITDA -11.84M EBIT -12.09M Earnings Per Share (EPS) -0.46
Full Income Statement Balance Sheet The company has 1.46M in cash and 260.16K in
debt, giving a net cash position of 1.2M.
Cash & Cash Equivalents 1.46M Total Debt 260.16K Net Cash 1.2M Retained Earnings -75M Total Assets 10.82M Working Capital 8.74M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -11.01M
and capital expenditures -120.2K, giving a free cash flow of -11.13M.
Operating Cash Flow -11.01M Capital Expenditures -120.2K Free Cash Flow -11.13M FCF Per Share -0.42
Full Cash Flow Statement Margins Gross margin is 31.27%, with operating and profit margins of -344.26% and -356.74%.
Gross Margin 31.27% Operating Margin -344.26% Pretax Margin -356.74% Profit Margin -356.74% EBITDA Margin -342.96% EBIT Margin -344.26% FCF Margin -322.39%
Dividends & Yields NMTC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for NMTC is $2.23,
which is 150.6% higher than the current price. The consensus rating is "Buy".
Price Target $2.23 Price Target Difference 150.6% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 1, 2021. It was a
backward
split with a ratio of 1:3.
Last Split Date Apr 1, 2021 Split Type backward Split Ratio 1:3
Scores Altman Z-Score -1.38 Piotroski F-Score 4
